- Share this article on Facebook
- Share this article on Twitter
- Share this article on Email
- Show additional share options
- Share this article on Print
- Share this article on Comment
- Share this article on Whatsapp
- Share this article on Linkedin
- Share this article on Reddit
- Share this article on Pinit
- Share this article on Tumblr
Heath Ledger has helped propel “The Dark Knight” to the top of the boxoffice. His presence might have a less beneficial effect on his next and final film, “The Imaginarium of Doctor Parnassus.”
For U.S. distributors, the quirky Terry Gilliam film — centering on parallel worlds, a theater troupe and a devil-dealing 1,000-year-old doctor — presents a conundrum. On the one hand, it’s a chance for the history-making opportunity — not to mention a marketing coup — of releasing Ledger’s last movie.
But it also comes with challenges that lately have followed the stubbornly noncommercial Gilliam. The director has been behind a series of boxoffice flops and hasn’t had a hit since “Twelve Monkeys” in 1995. Buyers who might otherwise be willing to shell out for a Ledger film are holding back.
“In this market, unless I have a reason to think a movie like this is going to be a slam dunk I’m not going to take a flyer on it, even with Heath Ledger,” one distribution executive said. One specialty exec added few execs at his company had been tracking it.
Those familiar with the project said that when it comes to commercial expectations, “Parnassus” is more of a mini-major play than a studio picture. The film, which has sold in many foreign territories, is being handled by Lionsgate, which has been mentioned as a candidate to pick up the film domestically.
Financed by Grosvenor Park and produced by Samuel Hadida’s Davis Films, “Parnassus” was said to be close to having footage shown and even a deal made several weeks ago, just as the buzz for “Dark Knight” was reaching fever pitch. But as of late last week, many buyers had yet to see footage.
That hadn’t stopped them from weighing in to say that the prestige value of distributing a Gilliam-Ledger film might be worthwhile — but only for a price.
Given that the film’s budget is somewhat more than $20 million, that could take a while. Recently, another challenging $20 million release, Charlie Kaufman’s “Synecdoche, New York,” didn’t spur buyers until the sellers finally decided on a more modest offer from Sony Pictures Classics.
That could put the late actor in a position of having one of the biggest- grossing movies in Hollywood history out at the same time he’s in a movie hunting for an domestic distribution deal.
Johnny Depp, Colin Farrell and Jude Law stepped in to the Ledger role after the actor died in January, with the script tweaked to reflect a shapeshifting element that allowed for other actors to play his role. The trio, who have said that they’re donating their fees to Ledger’s family, took over, as shooting moved from the U.K. to Vancouver.
The prospect of getting involved with three marketable stars makes for a relative bargain for a buyer, who might pay low-seven figures for domestic rights but get an eight-figure level of promotable talent.
But even that troika might not be enough.
Said one longtime distribution guru: “For all the elements in this film, it is a Terry Gilliam picture, and as much as you want a movie of his to be good, you have to be careful.”
Sign up for THR news straight to your inbox every day